Coloplast A/S (CLPBF)
OTCMKTS · Delayed Price · Currency is USD
96.80
+0.20 (0.21%)
Aug 29, 2025, 9:31 AM EDT
Revenue by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2013 - 2019 |
Ostomy Care | 9.55B | Log In | Log In | Log In | Log In | Upgrade |
Ostomy Care Growth | 5.00% | Log In | Log In | Log In | Log In | Upgrade |
Continence Care | 8.54B | Log In | Log In | Log In | Log In | Upgrade |
Continence Care Growth | 7.34% | Log In | Log In | Log In | Log In | Upgrade |
Interventional Urology | 2.78B | Log In | Log In | Log In | Log In | Upgrade |
Interventional Urology Growth | 2.23% | Log In | Log In | Log In | Log In | Upgrade |
Advanced Wound Dressings | 3.03B | Log In | Log In | Log In | Log In | Upgrade |
Advanced Wound Dressings Growth | -21.61% | Log In | Log In | Log In | Log In | Upgrade |
Voice and Respiratory Care | 2.11B | Log In | Log In | Log In | Log In | Upgrade |
Voice and Respiratory Care Growth | 8.98% | Log In | Log In | Log In | Log In | Upgrade |
Biologics | 1.03B | Log In | Log In | Log In | Log In | Upgrade |
Biologics Growth | 50.43% | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2013 - 2019 |
Chronic Care Segment EBIT | 10.44B | Log In | Log In | Log In | Log In | Upgrade |
Chronic Care Segment EBIT Growth | 5.94% | Log In | Log In | Log In | Log In | Upgrade |
Interventional Urology Segment EBIT | 976.00M | Log In | Log In | Log In | Log In | Upgrade |
Interventional Urology Segment EBIT Growth | -0.10% | Log In | Log In | Log In | Log In | Upgrade |
Advanced Wound Dressings Segment EBIT | 1.15B | Log In | Log In | Log In | Log In | Upgrade |
Advanced Wound Dressings Segment EBIT Growth | -0.35% | Log In | Log In | Log In | Log In | Upgrade |
Other | -6.10B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 6.54% | Log In | Log In | Log In | Log In | Upgrade |
Voice and Respiratory Care Segment EBIT | 736.00M | Log In | Log In | Log In | Log In | Upgrade |
Voice and Respiratory Care Segment EBIT Growth | 11.08% | Log In | Log In | Log In | Log In | Upgrade |
Biologics Segment EBIT | 101.00M | Log In | Log In | Log In | Log In | Upgrade |
Biologics Segment EBIT Growth | 58.14% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2013 - 2019 |
European Markets | 14.75B | Log In | Log In | Log In | Log In | Upgrade |
European Markets Growth | 4.86% | Log In | Log In | Log In | Log In | Upgrade |
Other Developed Markets | 7.75B | Log In | Log In | Log In | Log In | Upgrade |
Other Developed Markets Growth | 8.67% | Log In | Log In | Log In | Log In | Upgrade |
Emerging Markets | 4.53B | Log In | Log In | Log In | Log In | Upgrade |
Emerging Markets Growth | 4.96% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2013 - 2019 |
Ostomy Care Organic Growth | 7.00% | Log In | Log In | Log In | Log In | Upgrade |
Continence Care Organic Growth | 8.00% | Log In | Log In | Log In | Log In | Upgrade |
Advanced Wound Care Organic Growth | 10.00% | Log In | Log In | Log In | Log In | Upgrade |
Interventional Urology Organic Growth | 5.00% | Log In | Log In | Log In | Log In | Upgrade |
Total Organic Growth | 8.00% | Log In | Log In | Log In | Log In | Upgrade |
Voice and Respiratory Care Organic Growth | 11.00% | Log In | Log In | Log In | Log In | Upgrade |